back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-01 17:42 Tx date 2024-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,121
+4,059 vol $8.16 each |
151,927 | |
| Filed 2024-10-01 17:40 Tx date 2024-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,497
+7,659 vol $8.16 each |
260,295 | |
| Filed 2024-10-01 17:37 Tx date 2024-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,870
+842 vol $8.16 each |
207,094 | |
| Filed 2024-09-09 15:02 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-24,750 vol |
129,933 | |
| Filed 2024-09-09 15:01 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$404,751
+65,388 vol $6.19 each |
154,683 | |
| Filed 2024-09-09 15:00 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-404,751.72
-65,388 vol $6.19 each |
189,583 | |
| Filed 2024-09-09 14:57 Tx date 2024-09-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,027.70
-13,370 vol $6.21 each |
120,303 | |
| Filed 2024-09-09 14:56 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-51,337 vol |
133,673 | |
| Filed 2024-09-09 14:56 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$593,633
+95,902 vol $6.19 each |
185,010 | |
| Filed 2024-09-09 14:54 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-593,633.38
-95,902 vol $6.19 each |
321,208 | |
| Filed 2024-09-09 14:51 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-3,982 vol |
27,924 | |
| Filed 2024-09-09 14:50 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$71,952
+11,624 vol $6.19 each |
31,906 | |
| Filed 2024-09-09 14:49 Tx date 2024-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-71,952.56
-11,624 vol $6.19 each |
122,482 | |
| Filed 2024-09-03 14:18 Tx date 2024-08-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-14,683 vol |
393,585 | |
| Filed 2024-09-03 14:17 Tx date 2024-08-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$178,415
+30,087 vol $5.93 each |
408,268 | |
| Filed 2024-09-03 14:16 Tx date 2024-08-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-178,415.91
-30,087 vol $5.93 each |
893,555 | |
| Filed 2024-08-21 16:37 Tx date 2024-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Charhon, Jean-Jacques
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+298,838 vol |
298,838 | |
| Filed 2024-08-21 16:36 Tx date 2024-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Charhon, Jean-Jacques
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-08-21 16:36 Tx date 2024-08-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Charhon, Jean-Jacques
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+298,838 vol |
298,838 | |
| Filed 2024-08-21 16:35 Tx date 2024-08-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Charhon, Jean-Jacques
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-22 15:32 Tx date 2024-07-18 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+49,254 vol |
134,106 | |
| Filed 2024-07-17 19:01 Tx date 2024-07-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Lenar, Aimee
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+144,352 vol |
144,352 | |
| Filed 2024-07-17 19:01 Tx date 2024-07-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Lenar, Aimee
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-02 19:00 Tx date 2022-05-05 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-02 19:00 Tx date 2022-05-05 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-02 18:52 Tx date 2024-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$14,929
+2,142 vol $6.97 each |
227,421 | |
| Filed 2024-07-02 18:47 Tx date 2022-05-05 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Robertson, Russel Clark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-07-02 14:40 Tx date 2024-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,121
+4,752 vol $6.97 each |
147,868 | |
| Filed 2024-07-02 14:38 Tx date 2024-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+8,967 vol $6.97 each |
252,636 | |
| Filed 2024-07-02 14:34 Tx date 2024-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,872
+986 vol $6.97 each |
206,252 | |
| Filed 2016-08-11 10:06 Tx date 2016-06-14 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Robertson, Russel Clark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-21 15:34 Tx date 2016-03-08 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-15 18:14 Tx date 2016-03-08 |
$BHC
Valeant Pharmaceuticals International, Inc. |
Ross Sr., Thomas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-24 09:21 Tx date 2024-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,930 vol |
20,282 | |
| Filed 2024-06-24 09:21 Tx date 2024-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,633 vol |
22,212 | |
| Filed 2024-06-24 09:19 Tx date 2024-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,633 vol |
84,852 | |
| Filed 2024-05-21 17:25 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
205,266 | |
| Filed 2024-05-21 17:22 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
193,775 | |
| Filed 2024-05-21 17:19 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
243,669 | |
| Filed 2024-05-21 17:16 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
101,269 | |
| Filed 2024-05-21 17:13 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
124,033 | |
| Filed 2024-05-21 17:09 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
182,012 | |
| Filed 2024-05-21 17:01 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,995
+35,360 vol $7.07 each |
143,116 | |
| Filed 2024-05-21 16:58 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Lee, Frank Don
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$250,702
+35,460 vol $7.07 each |
35,460 | |
| Filed 2024-05-21 16:56 Tx date 2024-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Lee, Frank Don
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-21 16:44 Tx date 2024-05-17 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Garcia, Christian Albert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+35,360 vol |
35,360 | |
| Filed 2024-05-21 16:43 Tx date 2024-05-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Garcia, Christian Albert
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-01 17:33 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+3,122 vol |
107,756 | |
| Filed 2024-04-01 17:30 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+5,890 vol |
208,309 | |
| Filed 2024-04-01 17:28 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+647 vol |
169,906 | |
| Filed 2024-04-01 17:25 Tx date 2024-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+2,945 vol |
225,279 | |
| Filed 2024-03-05 16:23 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-8,484 vol |
89,295 | |
| Filed 2024-03-05 16:23 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+19,816 vol |
97,779 | |
| Filed 2024-03-05 16:22 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,816 vol |
254,971 | |
| Filed 2024-03-05 16:21 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-3,269 vol |
77,963 | |
| Filed 2024-03-05 16:20 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,634 vol |
81,232 | |
| Filed 2024-03-05 16:19 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,634 vol |
274,787 | |
| Filed 2024-03-05 16:18 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-451 vol |
73,598 | |
| Filed 2024-03-05 16:17 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,053 vol |
74,049 | |
| Filed 2024-03-05 16:17 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,053 vol |
282,421 | |
| Filed 2024-03-05 16:16 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-406 vol |
72,996 | |
| Filed 2024-03-05 16:15 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+948 vol |
73,402 | |
| Filed 2024-03-05 16:14 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-948 vol |
283,474 | |
| Filed 2024-03-05 16:12 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-16,973 vol |
89,108 | |
| Filed 2024-03-05 16:11 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+31,706 vol |
106,081 | |
| Filed 2024-03-05 16:11 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-31,706 vol |
417,110 | |
| Filed 2024-03-05 16:10 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-5,994 vol |
74,375 | |
| Filed 2024-03-05 16:09 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+11,197 vol |
80,369 | |
| Filed 2024-03-05 16:08 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,197 vol |
448,816 | |
| Filed 2024-03-05 16:07 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-511 vol |
69,172 | |
| Filed 2024-03-05 16:07 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+953 vol |
69,683 | |
| Filed 2024-03-05 16:06 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-953 vol |
460,013 | |
| Filed 2024-03-05 16:05 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-765 vol |
68,730 | |
| Filed 2024-03-05 16:03 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,429 vol |
69,495 | |
| Filed 2024-03-05 16:03 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,429 vol |
460,966 | |
| Filed 2024-03-05 15:57 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-3,188 vol |
16,579 | |
| Filed 2024-03-05 15:57 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,422 vol |
19,767 | |
| Filed 2024-03-05 15:56 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-8,422 vol |
90,485 | |
| Filed 2024-03-05 15:53 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-87,803 vol |
378,181 | |
| Filed 2024-03-05 15:52 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+174,385 vol |
465,984 | |
| Filed 2024-03-05 15:51 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-174,385 vol |
923,642 | |
| Filed 2024-03-05 15:50 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-23,871 vol |
291,599 | |
| Filed 2024-03-05 15:49 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,897 vol |
315,470 | |
| Filed 2024-03-05 15:48 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,897 vol |
1,098,027 | |
| Filed 2024-03-05 15:47 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-2,413 vol |
264,573 | |
| Filed 2024-03-05 15:46 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,944 vol |
266,986 | |
| Filed 2024-03-05 15:45 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,944 vol |
1,148,924 | |
| Filed 2024-03-05 15:44 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-2,895 vol |
262,042 | |
| Filed 2024-03-05 15:44 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,932 vol |
264,937 | |
| Filed 2024-03-05 15:42 Tx date 2024-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,932 vol |
1,153,868 | |
| Filed 2024-03-04 18:27 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+39,126 vol |
98,907 | |
| Filed 2024-03-04 18:25 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+73,768 vol |
284,422 | |
| Filed 2024-03-04 18:22 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+147,536 vol |
462,395 | |
| Filed 2024-03-04 18:18 Tx date 2024-02-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+519,328 vol |
1,159,800 | |
| Filed 2024-01-02 17:28 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,245
+3,896 vol $8.02 each |
222,334 | |
| Filed 2024-01-02 17:24 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,122
+4,130 vol $8.02 each |
104,634 | |
| Filed 2024-01-02 17:22 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
63,130 | |
| Filed 2024-01-02 17:18 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+7,793 vol $8.02 each |
202,419 | |
| Filed 2024-01-02 17:14 Tx date 2023-12-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,873
+857 vol $8.02 each |
169,259 | |
| Filed 2023-04-05 12:36 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
||
| Filed 2023-12-05 16:46 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,691 vol |
72,454 | |
| Filed 2023-12-05 16:45 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,158 vol |
74,145 | |
| Filed 2023-12-05 16:45 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
210,654 | |
| Filed 2023-12-05 16:28 Tx date 2023-12-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-220 vol |
68,066 | |
| Filed 2023-12-05 16:27 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
-1,691 vol |
68,286 | |
| Filed 2023-12-05 16:26 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,158 vol |
69,977 | |
| Filed 2023-12-05 16:26 Tx date 2023-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
314,859 | |
| Filed 2023-11-07 17:41 Tx date 2023-11-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-327.23
-43 vol $7.61 each |
66,819 | |
| Filed 2023-11-07 17:40 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,528.38
-334 vol $7.57 each |
66,862 | |
| Filed 2023-11-07 17:39 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,716
+623 vol $7.57 each |
67,196 | |
| Filed 2023-11-07 17:38 Tx date 2023-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
$-4,716.11
-623 vol $7.57 each |
318,017 | |
| Filed 2023-10-03 11:45 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,496
+7,603 vol $8.22 each |
194,626 | |
| Filed 2023-10-03 11:42 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,118
+4,029 vol $8.22 each |
100,504 | |
| Filed 2023-10-03 11:38 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,871
+836 vol $8.22 each |
168,402 | |
| Filed 2023-10-03 11:30 Tx date 2023-09-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,244
+3,801 vol $8.22 each |
218,438 | |
| Filed 2023-09-07 10:50 Tx date 2023-09-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-55,351.80
-6,685 vol $8.28 each |
66,573 | |
| Filed 2023-09-07 10:48 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-428,663.95
-51,337 vol $8.35 each |
73,258 | |
| Filed 2023-09-07 10:47 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800,781
+95,902 vol $8.35 each |
124,595 | |
| Filed 2023-09-07 10:47 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-95,902 vol |
318,640 | |
| Filed 2023-09-07 10:44 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-233,758.25
-27,995 vol $8.35 each |
70,987 | |
| Filed 2023-09-07 10:43 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$545,981
+65,387 vol $8.35 each |
98,982 | |
| Filed 2023-09-07 10:41 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-65,387 vol |
213,812 | |
| Filed 2023-09-07 10:36 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-366,965.80
-43,948 vol $8.35 each |
104,578 | |
| Filed 2023-09-07 10:33 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,043,441
+124,963 vol $8.35 each |
148,526 | |
| Filed 2023-09-07 10:29 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-124,963 vol |
460,355 | |
| Filed 2023-09-07 10:25 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-33,249.70
-3,982 vol $8.35 each |
11,345 | |
| Filed 2023-09-07 10:24 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$97,060
+11,624 vol $8.35 each |
15,327 | |
| Filed 2023-09-07 10:23 Tx date 2023-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,624 vol |
59,781 | |
| Filed 2023-09-05 18:21 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-119,379.06
-14,111 vol $8.46 each |
259,005 | |
| Filed 2023-09-05 18:20 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$254,536
+30,087 vol $8.46 each |
273,116 | |
| Filed 2023-09-05 18:20 Tx date 2023-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,087 vol |
640,472 | |
| Filed 2023-07-05 15:26 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$12,776
+1,597 vol $8.00 each |
94,147 | |
| Filed 2023-07-04 17:03 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$-31,529
-3,845 vol $8.20 each |
79,422 | |
| Filed 2023-07-04 17:02 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$92,036
+11,224 vol $8.20 each |
83,267 | |
| Filed 2023-07-04 17:02 Tx date 2023-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,224 vol |
38,272 | |
| Filed 2023-07-04 16:56 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,872
+859 vol $8.00 each |
167,566 | |
| Filed 2023-07-04 16:54 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,120
+4,140 vol $8.00 each |
96,475 | |
| Filed 2023-07-04 16:52 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,248
+3,906 vol $8.00 each |
214,637 | |
| Filed 2023-07-04 16:49 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,496
+7,812 vol $8.00 each |
187,023 | |
| Filed 2023-06-21 16:07 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,274.60
-1,929 vol $7.40 each |
3,703 | |
| Filed 2023-06-21 16:06 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,676
+5,632 vol $7.40 each |
5,632 | |
| Filed 2023-06-21 16:04 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-21 16:04 Tx date 2023-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,632 vol |
71,405 | |
| Filed 2023-05-23 13:00 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
166,707 | |
| Filed 2023-05-23 12:58 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
150,016 | |
| Filed 2023-05-23 12:57 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
210,731 | |
| Filed 2023-05-23 12:55 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
158,415 | |
| Filed 2023-05-23 12:53 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
179,211 | |
| Filed 2023-05-23 12:51 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
65,909 | |
| Filed 2023-05-23 12:49 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
88,673 | |
| Filed 2023-05-23 12:47 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
146,652 | |
| Filed 2023-05-23 12:44 Tx date 2023-05-19 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,994
+29,205 vol $8.56 each |
92,335 | |
| Filed 2023-04-28 16:08 Tx date 2023-04-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Bailey, Ambrose Robert Douglas
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-05 12:42 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,868
+848 vol $8.10 each |
137,502 | |
| Filed 2023-04-05 12:40 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
55 - Expiration of warrants
|
$33,291
+4,110 vol $8.10 each |
181,526 | |
| Filed 2023-04-05 12:38 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+7,716 vol $8.10 each |
150,006 | |
| Filed 2023-04-05 12:36 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,840
+3,684 vol $8.10 each |
63,130 | |
| Filed 2023-04-05 12:33 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,500
+3,642 vol $8.10 each |
92,550 | |
| Filed 2023-03-06 18:55 Tx date 2023-03-06 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,539.15
-495 vol $9.17 each |
28,693 | |
| Filed 2023-03-06 18:54 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,285.20
-780 vol $9.34 each |
29,188 | |
| Filed 2023-03-06 18:52 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,680.76
-511 vol $9.16 each |
29,968 | |
| Filed 2023-03-06 18:51 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,729
+953 vol $9.16 each |
30,479 | |
| Filed 2023-03-06 18:51 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,007.40
-765 vol $9.16 each |
29,526 | |
| Filed 2023-03-06 18:50 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,089
+1,429 vol $9.16 each |
30,291 | |
| Filed 2023-03-06 18:49 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,124.92
-887 vol $9.16 each |
28,862 | |
| Filed 2023-03-06 18:48 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,178
+1,657 vol $9.16 each |
29,749 | |
| Filed 2023-03-06 18:47 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,994.92
-1,637 vol $9.16 each |
28,092 | |
| Filed 2023-03-06 18:46 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,286
+3,058 vol $9.25 each |
29,729 | |
| Filed 2023-03-06 18:45 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-953 vol |
414,542 | |
| Filed 2023-03-06 18:45 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,429 vol |
415,495 | |
| Filed 2023-03-06 18:44 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,657 vol |
0 | |
| Filed 2023-03-06 18:43 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,058 vol |
1,657 | |
| Filed 2023-03-06 18:41 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-55,444.50
-5,994 vol $9.25 each |
26,671 | |
| Filed 2023-03-06 18:41 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$103,572
+11,197 vol $9.25 each |
32,665 | |
| Filed 2023-03-06 18:40 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,197 vol |
416,924 | |
| Filed 2023-03-06 18:38 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$879,850
+95,119 vol $9.25 each |
428,121 | |
| Filed 2023-03-06 18:37 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+82,117 vol |
265,698 | |
| Filed 2023-03-06 18:34 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,445.32
-1,577 vol $9.16 each |
243,029 | |
| Filed 2023-03-06 18:33 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-17,339.88
-1,893 vol $9.16 each |
244,606 | |
| Filed 2023-03-06 18:32 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,590.12
-2,357 vol $9.16 each |
246,499 | |
| Filed 2023-03-06 18:31 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,827.68
-4,348 vol $9.16 each |
248,856 | |
| Filed 2023-03-06 18:30 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$117,419
+12,694 vol $9.25 each |
253,204 | |
| Filed 2023-03-06 18:29 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,943 vol |
670,559 | |
| Filed 2023-03-06 18:29 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,932 vol |
675,502 | |
| Filed 2023-03-06 18:28 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,881 vol |
121,770 | |
| Filed 2023-03-06 18:27 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-12,694 vol |
128,651 | |
| Filed 2023-03-06 18:25 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-161,246
-17,432 vol $9.25 each |
240,510 | |
| Filed 2023-03-06 18:23 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$470,788
+50,896 vol $9.25 each |
257,942 | |
| Filed 2023-03-06 18:23 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-50,896 vol |
681,434 | |
| Filed 2023-03-06 18:21 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$4,839,183
+523,155 vol $9.25 each |
732,330 | |
| Filed 2023-03-06 18:18 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,645
+1,053 vol $9.16 each |
33,595 | |
| Filed 2023-03-06 18:17 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,683
+948 vol $9.16 each |
32,542 | |
| Filed 2023-03-06 18:13 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,131.16
-451 vol $9.16 each |
31,594 | |
| Filed 2023-03-06 18:13 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-3,718.96
-406 vol $9.16 each |
32,045 | |
| Filed 2023-03-06 18:12 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,053 vol |
279,199 | |
| Filed 2023-03-06 18:11 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-948 vol |
280,252 | |
| Filed 2023-03-06 18:10 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,314.36
-471 vol $9.16 each |
32,451 | |
| Filed 2023-03-06 18:09 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,950.88
-868 vol $9.16 each |
32,922 | |
| Filed 2023-03-06 18:08 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,066
+1,099 vol $9.16 each |
33,790 | |
| Filed 2023-03-06 18:08 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,567
+2,027 vol $9.16 each |
32,691 | |
| Filed 2023-03-06 18:07 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,099 vol |
0 | |
| Filed 2023-03-06 18:06 Tx date 2023-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,027 vol |
1,099 | |
| Filed 2023-03-06 17:55 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,009.25
-4,001 vol $9.25 each |
23,563 | |
| Filed 2023-03-06 17:54 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$134,957
+14,590 vol $9.25 each |
27,564 | |
| Filed 2023-03-06 17:54 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-14,590 vol |
585,318 | |
| Filed 2023-03-06 17:53 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$1,319,771
+142,678 vol $9.25 each |
599,908 | |
| Filed 2023-03-06 17:51 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+123,177 vol |
512,907 | |
| Filed 2023-03-06 17:46 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+21,812 vol |
21,812 | |
| Filed 2023-03-06 17:45 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-06 17:44 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$233,710
+25,266 vol $9.25 each |
77,037 | |
| Filed 2023-03-06 17:40 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-30,238.25
-3,269 vol $9.25 each |
30,664 | |
| Filed 2023-03-06 17:39 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$70,614
+7,634 vol $9.25 each |
33,933 | |
| Filed 2023-03-06 17:39 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,634 vol |
281,200 | |
| Filed 2023-03-06 17:37 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$549,903
+59,449 vol $9.25 each |
288,834 | |
| Filed 2023-03-06 17:36 Tx date 2023-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+51,324 vol |
176,998 | |
| Filed 2023-03-06 17:34 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,674 | ||
| Filed 2023-03-01 18:47 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-3,751.44
-392 vol $9.57 each |
26,299 | |
| Filed 2023-03-01 18:46 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,756
+915 vol $9.57 each |
26,691 | |
| Filed 2023-03-01 18:46 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-915 vol |
229,385 | |
| Filed 2023-03-01 18:45 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,196.64
-752 vol $9.57 each |
25,776 | |
| Filed 2023-03-01 18:44 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,804
+1,756 vol $9.57 each |
26,528 | |
| Filed 2023-03-01 18:43 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-1,756 vol |
3,126 | |
| Filed 2023-03-01 18:43 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
4,882 | ||
| Filed 2023-03-01 18:34 Tx date 2023-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,721.44
-292 vol $9.32 each |
21,468 | |
| Filed 2023-03-01 18:33 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,349.76
-768 vol $9.57 each |
21,760 | |
| Filed 2023-03-01 18:32 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,723
+1,434 vol $9.57 each |
22,528 | |
| Filed 2023-03-01 18:32 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,434 vol |
333,002 | |
| Filed 2023-03-01 18:30 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,106.18
-1,474 vol $9.57 each |
21,094 | |
| Filed 2023-03-01 18:30 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$26,336
+2,752 vol $9.57 each |
22,568 | |
| Filed 2023-03-01 18:29 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-2,752 vol |
4,715 | |
| Filed 2023-03-01 18:24 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-40,749.06
-4,258 vol $9.57 each |
207,046 | |
| Filed 2023-03-01 18:23 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$119,117
+12,447 vol $9.57 each |
211,304 | |
| Filed 2023-03-01 18:22 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-12,447 vol |
141,345 | |
| Filed 2023-03-01 18:21 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,800.33
-2,069 vol $9.57 each |
198,857 | |
| Filed 2023-03-01 18:21 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$62,042
+6,483 vol $9.57 each |
200,926 | |
| Filed 2023-03-01 18:20 Tx date 2023-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
209,175 | |
| Filed 2023-01-04 17:47 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,626.80
-6,310 vol $6.28 each |
12,974 | |
| Filed 2023-01-04 17:46 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$121,103
+19,284 vol $6.28 each |
19,284 | |
| Filed 2023-01-04 17:45 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-04 17:42 Tx date 2023-01-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-19,284 vol |
457,230 | |
| Filed 2023-01-04 17:07 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,870
+1,094 vol $6.28 each |
136,654 | |
| Filed 2023-01-04 17:05 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,370
+5,473 vol $6.28 each |
177,416 | |
| Filed 2023-01-04 17:03 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,498
+9,952 vol $6.28 each |
142,290 | |
| Filed 2023-01-04 17:01 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,818
+4,589 vol $6.28 each |
59,468 | |
| Filed 2023-01-04 16:59 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$28,818
+4,589 vol $6.28 each |
59,446 | |
| Filed 2023-01-04 16:57 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$32,568
+5,186 vol $6.28 each |
88,908 | |
| Filed 2022-12-02 12:42 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-13,020.70
-1,691 vol $7.70 each |
19,816 | |
| Filed 2022-12-02 12:39 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-10,418.10
-1,353 vol $7.70 each |
24,772 | |
| Filed 2022-12-02 12:38 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,316
+3,158 vol $7.70 each |
26,125 | |
| Filed 2022-12-02 12:37 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
22,967 | ||
| Filed 2022-12-02 12:34 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
230,300 | |
| Filed 2022-12-02 12:31 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-11,295.90
-1,467 vol $7.70 each |
||
| Filed 2022-12-02 12:30 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,316
+3,158 vol $7.70 each |
21,507 | |
| Filed 2022-12-02 12:30 Tx date 2022-12-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,158 vol |
334,436 | |
| Filed 2022-11-07 15:35 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,154.30
-334 vol $6.45 each |
18,349 | |
| Filed 2022-11-07 15:34 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,018
+623 vol $6.45 each |
18,683 | |
| Filed 2022-11-07 15:33 Tx date 2022-11-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-623 vol |
337,594 | |
| Filed 2022-10-04 16:41 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,869
+997 vol $6.89 each |
135,560 | |
| Filed 2022-10-04 16:39 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,374
+4,989 vol $6.89 each |
171,943 | |
| Filed 2022-10-04 16:36 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$62,499
+9,071 vol $6.89 each |
132,338 | |
| Filed 2022-10-04 16:34 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+4,444 vol $6.89 each |
54,879 | |
| Filed 2022-10-04 16:31 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+4,444 vol $6.89 each |
54,857 | |
| Filed 2022-10-04 16:28 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,374
+4,989 vol $6.89 each |
83,722 | |
| Filed 2022-09-15 15:30 Tx date 2022-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-762,430
-100,000 vol $7.62 each |
934,594 | |
| Filed 2022-09-15 15:29 Tx date 2022-09-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-389,000
-50,000 vol $7.78 each |
1,034,594 | |
| Filed 2022-09-15 15:26 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-26,665.28
-3,623 vol $7.36 each |
1,084,594 | |
| Filed 2022-09-15 15:26 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$52,130
+7,083 vol $7.36 each |
1,088,217 | |
| Filed 2022-09-15 15:25 Tx date 2022-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,083 vol |
76,448 | |
| Filed 2022-09-09 12:01 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+196,163 vol |
233,458 | |
| Filed 2022-09-09 12:00 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Dautbegovic, Mirza
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
37,295 | ||
| Filed 2022-09-08 11:09 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,873 vol |
51,771 | |
| Filed 2022-09-08 11:07 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+287,707 vol |
338,217 | |
| Filed 2022-09-08 11:05 Tx date 2022-09-05 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Tom George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+374,891 vol |
476,514 | |
| Filed 2022-09-06 10:22 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-101,413.51
-15,389 vol $6.59 each |
194,443 | |
| Filed 2022-09-06 10:21 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$198,266
+30,086 vol $6.59 each |
209,832 | |
| Filed 2022-09-06 10:21 Tx date 2022-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-30,086 vol |
215,658 | |
| Filed 2022-07-06 15:06 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,871
+822 vol $8.36 each |
134,563 | |
| Filed 2022-07-06 15:04 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$36,065
+4,314 vol $8.36 each |
166,954 | |
| Filed 2022-07-06 15:02 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$18,818
+2,251 vol $8.36 each |
123,267 | |
| Filed 2022-07-06 15:00 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,622
+3,663 vol $8.36 each |
50,435 | |
| Filed 2022-07-06 14:58 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,622
+3,663 vol $8.36 each |
50,413 | |
| Filed 2022-07-06 14:42 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,367
+4,111 vol $8.36 each |
78,733 | |
| Filed 2022-06-29 13:11 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
133,741 | |
| Filed 2022-06-29 13:09 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ross Sr., Thomas
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
120,811 | |
| Filed 2022-06-29 13:08 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
162,640 | |
| Filed 2022-06-29 13:06 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Power, Robert Noel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
129,210 | |
| Filed 2022-06-29 13:05 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
121,016 | |
| Filed 2022-06-29 13:02 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
||
| Filed 2022-06-29 12:59 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
36,704 | |
| Filed 2022-06-29 12:58 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
46,772 | |
| Filed 2022-06-29 12:56 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Kavanagh, Sarah Baldwin
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
117,447 | |
| Filed 2022-06-29 12:53 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Karabelas, Argeris
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
119,715 | |
| Filed 2022-06-29 12:52 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
46,750 | |
| Filed 2022-06-29 12:49 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
74,622 | |
| Filed 2022-06-23 11:55 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+16,898 vol |
16,898 | |
| Filed 2022-06-23 11:54 Tx date 2022-06-20 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Barresi, John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-03 15:00 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
97 - Other
|
$-38,835.06
-4,058 vol $9.57 each |
72,043 | |
| Filed 2022-06-03 14:59 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,413
+11,224 vol $9.57 each |
76,101 | |
| Filed 2022-06-03 14:58 Tx date 2022-06-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,224 vol |
49,496 | |
| Filed 2022-05-17 19:00 Tx date 2022-05-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+2,317 vol |
2,317 | |
| Filed 2022-05-17 18:52 Tx date 2022-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,753
+3,293 vol $10.25 each |
8,500 | |
| Filed 2022-05-17 18:52 Tx date 2022-05-12 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Von Eschenbach, Andrew Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,496
+1,707 vol $10.25 each |
5,207 | |
| Filed 2022-05-16 17:04 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-316,911.60
-33,714 vol $9.40 each |
1,081,134 | |
| Filed 2022-05-16 17:03 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$619,563
+65,911 vol $9.40 each |
1,114,848 | |
| Filed 2022-05-16 17:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-65,911 vol |
983,705 | |
| Filed 2022-05-16 17:00 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$619,563
+65,911 vol $9.40 each |
1,049,616 | |
| Filed 2022-05-16 16:57 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$1,725,106
+183,522 vol $9.40 each |
983,705 | |
| Filed 2022-05-16 16:56 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$1,096,951
+116,697 vol $9.40 each |
800,183 | |
| Filed 2022-05-16 16:54 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$127,764
+13,592 vol $9.40 each |
74,983 | |
| Filed 2022-05-16 16:53 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$81,244
+8,643 vol $9.40 each |
61,391 | |
| Filed 2022-05-16 16:51 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$44,321
+4,715 vol $9.40 each |
7,467 | |
| Filed 2022-05-16 16:50 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$25,868
+2,752 vol $9.40 each |
2,752 | |
| Filed 2022-05-16 16:49 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-16 16:46 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$117,001
+12,447 vol $9.40 each |
134,217 | |
| Filed 2022-05-16 16:45 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$184,005
+19,575 vol $9.40 each |
153,792 | |
| Filed 2022-05-16 16:43 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$-117,001.80
-12,447 vol $9.40 each |
||
| Filed 2022-05-13 19:05 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
183,581 | ||
| Filed 2022-05-13 19:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
50,510 | ||
| Filed 2022-05-13 19:02 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Carson, Seana Lynne
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,060 | ||
| Filed 2022-05-13 18:59 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-13 18:59 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Mulligan, Richard Charles
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-05-13 17:24 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Thomas George
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
389,730 | ||
| Filed 2022-05-13 17:20 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Vadaketh, Thomas George
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
101,623 | ||
| Filed 2022-04-18 13:27 Tx date 2022-04-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,393.05
-1,595 vol $22.19 each |
24,617 | |
| Filed 2022-04-05 12:06 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Robertson, Russel Clark
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$38,113
+1,668 vol $22.85 each |
128,253 | |
| Filed 2022-04-05 12:05 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Icahn, Brett
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
12,363 | |
| Filed 2022-04-05 12:02 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$6,855
+300 vol $22.85 each |
99,354 | |
| Filed 2022-04-05 11:59 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Miller, Steven Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
12,385 | |
| Filed 2022-04-05 11:57 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,366
+1,504 vol $22.85 each |
40,235 | |
| Filed 2022-04-05 11:55 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Paulson, John
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$30,619
+1,340 vol $22.85 each |
86,629 | |
| Filed 2022-03-20 23:37 Tx date 2022-03-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-107,581.20
-4,846 vol $22.20 each |
26,212 | |
| Filed 2022-03-11 16:15 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-18,927.84
-839 vol $22.56 each |
111,345 | |
| Filed 2022-03-11 16:14 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,005
+1,463 vol $22.56 each |
112,184 | |
| Filed 2022-03-11 16:13 Tx date 2022-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,463 vol |
50,895 | |
| Filed 2022-03-10 16:27 Tx date 2022-03-08 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-84,624.64
-3,889 vol $21.76 each |
72,708 | |
| Filed 2022-03-08 11:19 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-96,187.14
-4,074 vol $23.61 each |
31,058 | |
| Filed 2022-03-08 11:18 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$188,006
+7,963 vol $23.61 each |
35,132 | |
| Filed 2022-03-08 11:18 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,963 vol |
65,889 | |
| Filed 2022-03-08 11:15 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-14,354.88
-608 vol $23.61 each |
10,958 | |
| Filed 2022-03-08 11:14 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$41,860
+1,773 vol $23.61 each |
11,566 | |
| Filed 2022-03-08 11:13 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-1,773 vol |
12,224 | |
| Filed 2022-03-08 11:09 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-163,522.86
-6,926 vol $23.61 each |
110,721 | |
| Filed 2022-03-08 11:09 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$285,279
+12,083 vol $23.61 each |
117,647 | |
| Filed 2022-03-08 11:08 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-12,083 vol |
52,358 | |
| Filed 2022-03-08 10:53 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-29,323.62
-1,242 vol $23.61 each |
64,877 | |
| Filed 2022-03-08 10:53 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,029
+3,432 vol $23.61 each |
66,119 | |
| Filed 2022-03-08 10:52 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,432 vol |
60,720 | |
| Filed 2022-03-08 10:48 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-298,501.23
-12,643 vol $23.61 each |
1,048,937 | |
| Filed 2022-03-08 10:48 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$583,544
+24,716 vol $23.61 each |
1,061,580 | |
| Filed 2022-03-08 10:47 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-24,716 vol |
83,531 | |
| Filed 2022-03-08 10:44 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-96,187.14
-4,074 vol $23.61 each |
76,597 | |
| Filed 2022-03-08 10:42 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$188,006
+7,963 vol $23.61 each |
80,671 | |
| Filed 2022-03-08 10:41 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,963 vol |
20,431 | |
| Filed 2022-03-08 10:35 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-131,366.04
-5,564 vol $23.61 each |
179,746 | |
| Filed 2022-03-08 10:33 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$256,758
+10,875 vol $23.61 each |
185,310 | |
| Filed 2022-03-08 10:31 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,875 vol |
245,744 | |
| Filed 2022-03-04 17:17 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-258,869.49
-11,077 vol $23.37 each |
72,708 | |
| Filed 2022-03-04 17:12 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+565,330 vol |
852,455 | |
| Filed 2022-03-04 17:11 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$3,690,517
+152,690 vol $24.17 each |
256,619 | |
| Filed 2022-03-04 16:55 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+131,910 vol |
323,356 | |
| Filed 2022-03-04 16:53 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$861,104
+35,627 vol $24.17 each |
73,852 | |
| Filed 2022-03-04 16:52 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,275.15
-1,595 vol $23.37 each |
27,169 | |
| Filed 2022-03-03 18:36 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-40,201.85
-1,651 vol $24.35 each |
28,764 | |
| Filed 2022-03-03 18:35 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,641.80
-1,628 vol $24.35 each |
15,879 | |
| Filed 2022-03-03 18:34 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-137,480.10
-5,646 vol $24.35 each |
30,415 | |
| Filed 2022-03-03 18:33 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$111,206
+4,567 vol $24.35 each |
36,061 | |
| Filed 2022-03-03 18:33 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,623
+4,502 vol $24.35 each |
17,507 | |
| Filed 2022-03-03 18:32 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$380,225
+15,615 vol $24.35 each |
31,494 | |
| Filed 2022-03-03 18:31 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,567 vol |
38,225 | |
| Filed 2022-03-03 18:31 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,502 vol |
42,792 | |
| Filed 2022-03-03 18:29 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-15,615 vol |
52,748 | |
| Filed 2022-03-03 18:28 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+15,615 vol |
68,363 | |
| Filed 2022-03-03 18:26 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,132.90
-334 vol $24.35 each |
9,793 | |
| Filed 2022-03-03 18:26 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-7,451.10
-306 vol $24.35 each |
7,141 | |
| Filed 2022-03-03 18:25 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,716
+974 vol $24.35 each |
10,127 | |
| Filed 2022-03-03 18:24 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,695
+891 vol $24.35 each |
7,447 | |
| Filed 2022-03-03 18:24 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-32,093.30
-1,318 vol $24.35 each |
9,153 | |
| Filed 2022-03-03 18:23 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,085
+3,330 vol $24.35 each |
10,471 | |
| Filed 2022-03-03 18:22 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-974 vol |
13,997 | |
| Filed 2022-03-03 18:21 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-891 vol |
14,971 | |
| Filed 2022-03-03 18:19 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,330 vol |
0 | |
| Filed 2022-03-03 18:19 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+3,330 vol |
3,330 | |
| Filed 2022-03-03 18:17 Tx date 2021-06-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Munsch, Frederick John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-03 18:13 Tx date 2022-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-150,971.16
-6,338 vol $23.82 each |
83,785 | |
| Filed 2022-03-03 18:12 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-41,784.60
-1,716 vol $24.35 each |
90,123 | |
| Filed 2022-03-03 18:10 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$123,551
+5,074 vol $24.35 each |
91,839 | |
| Filed 2022-03-03 18:09 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-37,060.70
-1,522 vol $24.35 each |
75,648 | |
| Filed 2022-03-03 18:08 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,623
+4,502 vol $24.35 each |
77,170 | |
| Filed 2022-03-03 18:01 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-5,074 vol |
28,394 | |
| Filed 2022-03-03 18:00 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,502 vol |
33,468 | |
| Filed 2022-03-03 17:58 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-151,773.55
-6,233 vol $24.35 each |
83,785 | |
| Filed 2022-03-03 17:57 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$422,472
+17,350 vol $24.35 each |
90,018 | |
| Filed 2022-03-03 17:56 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-17,350 vol |
16,073 | |
| Filed 2022-03-03 17:56 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Gordon, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+17,350 vol |
33,423 | |
| Filed 2022-03-03 17:53 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$61,775
+2,537 vol $24.35 each |
64,419 | |
| Filed 2022-03-03 17:51 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-22,353.30
-918 vol $24.35 each |
62,687 | |
| Filed 2022-03-03 17:50 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-19,820.90
-814 vol $24.35 each |
63,605 | |
| Filed 2022-03-03 17:48 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-61,775.95
-2,537 vol $24.35 each |
||
| Filed 2022-03-03 17:47 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$54,811
+2,251 vol $24.35 each |
56,310 | |
| Filed 2022-03-03 17:46 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,537 vol |
64,152 | |
| Filed 2022-03-03 17:45 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-2,251 vol |
66,689 | |
| Filed 2022-03-03 17:43 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-75,533.70
-3,102 vol $24.35 each |
61,882 | |
| Filed 2022-03-03 17:42 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$211,211
+8,674 vol $24.35 each |
64,984 | |
| Filed 2022-03-03 17:40 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-8,674 vol |
6,412 | |
| Filed 2022-03-03 17:39 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Eldessouky, Osama
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,674 vol |
15,086 | |
| Filed 2022-03-03 17:35 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-58,488.70
-2,402 vol $24.35 each |
174,435 | |
| Filed 2022-03-03 17:34 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-53,375.20
-2,192 vol $24.35 each |
154,223 | |
| Filed 2022-03-03 17:33 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,982
+7,104 vol $24.35 each |
176,837 | |
| Filed 2022-03-03 17:32 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$157,861
+6,483 vol $24.35 each |
156,415 | |
| Filed 2022-03-03 17:30 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,104 vol |
103,929 | |
| Filed 2022-03-03 17:29 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
111,033 | |
| Filed 2022-03-03 17:26 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-213,841.70
-8,782 vol $24.35 each |
169,733 | |
| Filed 2022-03-03 17:25 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$591,510
+24,292 vol $24.35 each |
178,515 | |
| Filed 2022-03-03 17:24 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-24,292 vol |
121,770 | |
| Filed 2022-03-03 17:23 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Appio, Thomas
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,292 vol |
146,062 | |
| Filed 2022-03-03 17:18 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-73,196.10
-3,006 vol $24.35 each |
105,564 | |
| Filed 2022-03-03 17:17 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-66,792.05
-2,743 vol $24.35 each |
108,570 | |
| Filed 2022-03-03 17:16 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$172,982
+7,104 vol $24.35 each |
111,313 | |
| Filed 2022-03-03 17:14 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$157,861
+6,483 vol $24.35 each |
90,196 | |
| Filed 2022-03-03 17:12 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,104 vol |
64,441 | |
| Filed 2022-03-03 17:11 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-6,483 vol |
71,545 | |
| Filed 2022-03-03 16:55 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-250,293.65
-10,279 vol $24.35 each |
97,726 | |
| Filed 2022-03-03 16:53 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$591,510
+24,292 vol $24.35 each |
108,005 | |
| Filed 2022-03-03 16:52 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-24,292 vol |
49,613 | |
| Filed 2022-03-03 16:50 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Ackermann, Christina
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+24,292 vol |
73,905 | |
| Filed 2022-03-03 15:35 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-321,566.10
-13,206 vol $24.35 each |
1,031,979 | |
| Filed 2022-03-03 15:34 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$658,935
+27,061 vol $24.35 each |
1,045,185 | |
| Filed 2022-03-03 15:33 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-321,006.05
-13,183 vol $24.35 each |
910,244 | |
| Filed 2022-03-03 15:32 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$657,766
+27,013 vol $24.35 each |
923,427 | |
| Filed 2022-03-03 15:30 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,061 vol |
118,247 | |
| Filed 2022-03-03 15:29 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-27,013 vol |
145,308 | |
| Filed 2022-03-03 15:15 Tx date 2022-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-123,066.90
-5,115 vol $24.06 each |
1,036,864 | |
| Filed 2022-03-03 15:14 Tx date 2022-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$240,600
+10,000 vol $24.06 each |
1,041,979 | |
| Filed 2022-03-03 15:13 Tx date 2022-02-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,000 vol |
108,247 | |
| Filed 2022-03-03 15:06 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-2,443,546.85
-100,351 vol $24.35 each |
1,018,124 | |
| Filed 2022-03-03 15:05 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,070,424
+208,231 vol $24.35 each |
1,118,475 | |
| Filed 2022-03-03 15:03 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-208,231 vol |
683,486 | |
| Filed 2022-03-03 15:02 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Papa, Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+208,231 vol |
891,717 | |
| Filed 2022-02-17 17:15 Tx date 2022-02-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,340.02
-3,251 vol $25.02 each |
13,005 | |
| Filed 2022-01-21 11:03 Tx date 2022-01-18 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,574.13
-3,251 vol $26.63 each |
16,256 | |
| Filed 2022-01-04 13:03 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,245 vol |
38,731 | |
| Filed 2022-01-04 13:00 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Wechsler, Amy
4 - Director of Issuer
Direct Ownership
|